{"abstract":"The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on August 5, 2025. That notice requires a correction in the SUPPLEMENTARY INFORMATION section.","action":"Notice; correction.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/02/20/2026-03337.html","cfr_references":[],"citation":"91 FR 8261","comment_url":null,"comments_close_on":"2026-03-09","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before March 9, 2026 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2026-03337","effective_on":null,"end_page":8262,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/02/20/2026-03337.xml","html_url":"https://www.federalregister.gov/documents/2026/02/20/2026-03337/prospective-grant-of-an-exclusive-patent-license-in-vivo-manufactured-anti-cd19-chimeric-antigen","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-03337?publication_date=2026-02-20","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-02-20/2026-03337/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":153,"last_updated":"2026-10-23 22:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-20/pdf/2026-03337.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03337.pdf?1771508710","publication_date":"2026-02-20","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/02/20/2026-03337.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2026-02-20T09:09:01Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":8261,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Products for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases","toc_doc":"In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor Products for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases; Correction","toc_subject":"Licenses; Exemptions, Applications, Amendments, etc.","topics":[],"type":"Notice","volume":91}